Kennedy Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.68M | Buy |
5,106
+90
| +2% | +$47.3K | 0.06% | 396 |
|
|
2025
Q1 | $3.18M | Sell |
5,016
-140
| -3% | -$88.8K | 0.08% | 361 |
|
|
2024
Q4 | $3.67M | Buy |
5,156
+652
| +14% | +$464K | 0.08% | 383 |
|
|
2024
Q3 | $4.73M | Sell |
4,504
-3,581
| -44% | -$3.76M | 0.1% | 330 |
|
|
2024
Q2 | $8.5M | Buy |
8,085
+2,672
| +49% | +$2.81M | 0.18% | 189 |
|
|
2024
Q1 | $5.21M | Buy |
+5,413
| New | +$5.21M | 0.11% | 313 |
|